The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.

The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.

Item
http://www.wikidata.org/entity/Q38036769
Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the DiseaseImportance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.Economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patients.Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes.Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox.Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials.
P2860

The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.

Item
http://www.wikidata.org/entity/Q38036769
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.
@en
type
label
The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.
@en
prefLabel
The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921